Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.
The recent evolution in single-cell technology has offered additional opportunities for understanding intra-cancer cell heterogeneity, distinguishing rare cell types, and determining the level of mutation, all of which can assist in therapy and diagnosis options.
Our 3rd Annual MarketsandMarkets Single-Cell Analysis Conference scheduled to be held on 23rd and 24th June 2022 in Boston, USA aims to bring together the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and also provides the platform to share the knowledge with academic peers and present their research papers and reports.
Designation- Professors, Researchers, Associate professors, Directors - Specializing in Genetics, Translational medicine, Cell therapy ,Cell biology etc
Department of System Biology, Department of Biomedical Engineering, Department of Hematology etc
CEO, COO, Senior Scientist, Research Scientist, Single Cell Specialist etc